Stocks
Agios Pharmaceuticals, Inc.AGIO
NASDAQHealthcareBiotechnology$27.85+0.94%
Focused on therapies targeting cellular metabolism, this biotechnology company develops treatments for rare genetic diseases and previously pursued oncology programs. Its lead commercial product, Pyrukynd, is approved for pyruvate kinase deficiency, with additional studies exploring expanded indicat...
Market Cap: $1.6B52W Range: $22.24 – $46.00
Congressional Interest in Agios Pharmaceuticals, Inc. (AGIO)
4 members of Congress have disclosed 6 trades in Agios Pharmaceuticals, Inc. (AGIO), a Healthcare company. The buy/sell breakdown shows 4 purchases versus 2 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
6
Unique Politicians
4
Buys
4
Sells
2
Who in Congress Is Trading AGIO?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-04-17 | Gilbert Cisneros | buy | $1K – $15K |
| 2025-01-29 | Gilbert Cisneros | buy | $1K – $15K |